PS-2020a / part16

DICOM PS3.16 2020a - Content Mapping Resource​

Page 1181​

Code Value​

Code Meaning​

Definition​

Notes​

111302​

Angiosarcoma​

A malignant neoplasm occurring most often in breast​

Retired. Replaced by​

and skin, believed to originate from endothelial cells of​(39000009, SCT,​

blood vessels, microscopically composed of closely​

"Angiosarcoma").​

packed round or spindle shaped cells, some of which​

line small spaces resembling vascular clefts​

111303​

Bloodvessel(vascular)invasion​Histological changes to the vascular system related to​

an invasive process.​

111304​

Carcinoma in children​

Carcinoma of the breast found in patients less than 20​

years of age.​

111305​

Carcinoma in ectopic breast​

A carcinoma found in supernumerary breasts and​

aberrant breast tissue.​

111306​

Carcinoma with endocrine​

A carcinoma that synthesizes substances, including​

differentiation​

hormones, not considered to be normal products of the​

breast.​

111307​

Basal cell carcinoma of nipple​A basal cell carcinoma that arises in the nipple of the​

breast.​

111308​

Carcinoma with metaplasia​

Retired. Replaced by​

(22694002,SCT,"Carcinoma​

with metaplasia").​

111309​

Cartilaginous and osseous​

Tissue changes to bones and cartilage.​

change​

111310​

Carcinoma in pregnancy and​

Carcinoma of the breast presenting during pregnancy or​

lactation​

lactation.​

111311​

Carcinosarcoma​

A malignant neoplasm that contains elements of​

Retired. Replaced by​

carcinoma and sarcoma, so extensively intermixed as to​(63264007, SCT,​

indicate neoplasia of epithelial and mesenchymal tissue​"Carcinosarcoma").​

111312​

Intraductal comedocarcinoma​ Comedocarcinomaofaductwithareasofnecrotictissue.​

with necrosis​

111313​

Intraductalcarcinoma,lowgrade​A non-invasive carcinoma restricted to the glandular​

lumen characterized by less aggressive malignant​

cytologic features and behavior.​

111314​

Intraductal carcinoma​

Retired. Replaced by​

micro-papillary​

(128696009, SCT,​

"Intraductal carcinoma​

micro-papillary").​

111315​

Intracystic papillary carcinoma​A malignant neoplasm characterized by the formation of​

numerous, irregular, finger-like projections of fibrous​

stroma that is covered with a surface layer of neoplastic​

epithelial cells found in a cyst.​

111316​

Invasive and in-situ carcinoma​Carcinoma with both characteristics of localized and​

spreading disease.​

111317​

Invasive lobular carcinoma​

Retired. Replaced by​

(89740008, SCT, "Invasive​

lobular carcinoma").​

111318​

Leukemic infiltration​

Mammary infiltrates as a secondary manifestation in​

patients with established leukemia.​

111320​

Lympathic vessel invasion​

Histological changes to the lymphatic system related to​

an invasive process.​

111321​

Lymphoma​

A heterogeneous group of neoplasms arising in the​

Retired. Replaced by​

reticuloendoethelial and lymphatic systems​

(21964009, SCT,​

"Lymphoma").​

Page 1182​

DICOM PS3.16 2020a - Content Mapping Resource​

Code Value​

Code Meaning​

Definition​

Notes​

111322​

Occult carcinoma presenting​

A small carcinoma, either asymptomatic or giving rise to​

with axillary lymph node​

metastases without symptoms due to the primary​

metastases​

carcinoma presenting with metastatic disease in the​

axillary lymph nodes.​

111323​

Metastatic cancer to the breast​Amalignantlesioninthebreastwithmorphologicpatterns​

not typical of breast carcinoma arising from a​

non-mammary malignant neoplasm.​

111324​

Metastatic cancer to the breast​Amalignantlesioninthebreastwithmorphologicpatterns​

from the colon​

not typical of breast carcinoma arising from a neoplasm​

in the colon.​

111325​

Metastatic cancer to the breast​Amalignantlesioninthebreastwithmorphologicpatterns​

from the lung​

not typical of breast carcinoma arising from a neoplasm​

in the lung.​

111326​ Metastatic melanoma to the​

Amalignantlesioninthebreastwithmorphologicpatterns​

breast​

nottypicalofbreastcarcinomaarisingfromamelanoma.​

111327​

Metastatic cancer to the breast​Amalignantlesioninthebreastwithmorphologicpatterns​

from the ovary​

not typical of breast carcinoma arising from a neoplasm​

in the ovary.​

111330​

Metastatic disease to axillary​

A malignant lesion in an axillary node arising from a​

node​

non-axillary neoplasm.​

111331​

Malignant fibrous histiocytoma​

Retired. Replaced by​

(34360000, SCT, "Malignant​

fibrous histiocytoma").​

111332​

Multifocal invasive ductal​

Multiple sites of ductal carcinoma.​

carcinoma​

111333​

Metastasis to an intramammary​Amalignantlesioninaintramammarylymphnodearising​

lymph node​

from a non-intramammary lymph node neoplasm.​

111334​

Malignant melanoma of nipple​Amalignantmelanomaoftheskinthatarisesinthenipple​

of the breast.​

111335​

Neoplasm of the mammary skin​

Retired. Replaced by​

(126510002,SCT,"Neoplasm​

of the mammary skin").​

111336​

Papillary carcinoma in-situ​

Retired. Replaced by​

(10376009, SCT, "Papillary​

carcinoma in-situ").​

111338​

Recurrent malignancy​

Recurrent malignancy.​

111340​

Squamouscellcarcinomaofthe​Squamous cell carcinoma to the terminal portion of the​

nipple​

alveolar.​

111341​

Intraductal carcinoma, high​

A non-invasive carcinoma restricted to the glandular​

grade​

lumen characterized by more aggressive malignant​

cytologic features and behavior.​

111342​

Invasive cribriform carcinoma​

Retired. Replaced by​

(30156004, SCT, "Invasive​

cribriform carcinoma").​

111343​

Angular margins​

An indication that some or all of the margin of a lesion​

has sharp corners, often forming acute angles.​

Page 1184​

DICOM PS3.16 2020a - Content Mapping Resource​

Code Value​

Code Meaning​

Definition​

Notes​

111371​ Identifiableeffectonsurrounding​Sonographic appearance of adjacent structures relative​

tissues​

to a mass finding.​

111372​

Vascularity​

Characterization of vascularization in region of interest.​

111373​

Vascularity not present​

Vascularity not evident, such as on ultrasound.​

111374​

Vascularity not assessed​

Vascularity not evaluated.​

111375​ Vascularity present in lesion​

Vascularity on imaging is seen within a lesion.​

111376​ Vascularitypresentimmediately​Vascularity on imaging is seen immediately adjacent to​

adjacent to lesion​

a lesion.​

111377​ Diffusely increased vascularity​Vascularity on imaging is considered diffusely elevated​

in surrounding tissue​

within the surrounding breast tissue.​

111380​ Correlation to other Findings​

Relationship of the new anomaly to other clinical or​

imaging anomalies.​

111381​ Correlates to physical exam​

An indication that the current imaging finding relates to​

findings​

a finding from a clinical breast exam.​

111382​

Correlates to mammography​

An indication that the current imaging finding relates to​

findings​

a finding from a mammography exam.​

111383​ Correlates to MRI findings​

An indication that the current imaging finding relates to​

a finding from a breast MRI exam.​

111384​

Correlatestoultrasoundfindings​An indication that the current imaging finding relates to​

a finding from a breast ultrasound exam.​

findings​

relation to findings from any other imaging exam.​

111387​

Nocorrelationtoclinicalfindings​An indication that the current imaging finding has no​

relation to any other clinical findings.​

111388​

Malignancy Type​

Classification of the cancer as invasive, DCIS, or other.​

111389​

Invasive breast carcinoma​

A malignancy that has spread beyond an area of focus.​

111390​

Other malignancy type​

A breast cancer with malignant pathology findings that​

are not classified as invasive or in situ.​

111391​

Menstrual Cycle Phase​

A specific timeframe during menses.​

111392​

1st week​

In the first week of the menstrual cycle phase, that is,​

one week following menses.​

111393​

2nd week​

In the second week of the menstrual cycle phase, that​

is, two weeks following menses.​

111394​

3rd week​

In the third week of the menstrual cycle phase, that is,​

three weeks following menses.​

111395​

Estimated Timeframe​

An estimated period of time.​

111396​ < 3 months ago​

An event occurred less than 3 months ago.​

111397​ 4 months to 1 year ago​

An event occurred between 4 months and 1 year ago.​

111398​ > 1 year ago​

An event occurred longer than 1 year ago.​

111399​

Timeframe uncertain​

The timing of an event is not recalled.​

111400​

Breast Imaging Report​

Report title for the diagnostic report for one or more​

breast imaging or intervention procedures.​

111401​

Reason for procedure​

Concept name for the description of why a procedure​

has been performed.​

DICOM PS3.16 2020a - Content Mapping Resource​

Page 1185​

Code Value​

Code Meaning​

Definition​

Notes​

111402​

Clinical Finding​

A finding during clinical examination (i.e., history and​

physical examination) such as pain, palpable mass or​

discharge.​

111403​

Baseline screening​

First screening mammogram taken for patient that is​

mammogram​

usedasacomparisonbaselineforfurtherexaminations.​

111404​

First mammogram ever​

First mammogram taken for a patient without regard to​

whether it was for screening or a diagnostic procedure.​

111405​

Implant type​

Concept name for the material of which a breast​

prosthetic device is constructed.​

111406​

Number of similar findings​

Anumericcountoffindingsclassifiedassimilarinnature.​

111407​

Implant finding​

Conceptnameforthestatusofabreastprostheticdevice​

as noted by imaging.​

111408​

Film Screen Mammography​

Mammogram using traditional X-Ray film.​

111409​

Digital Mammography​

Mammogram using a digital image acquisition system.​Retired​

Replaced by (46342-2, LN,​

"breast ffd mammogram").​

111410​

Surgical consult​

Referred for evaluation by a surgeon.​

111411​

Mammography CAD​

Computer aided detection and/or computer aided​

diagnosis for mammography.​

111412​

Narrative Summary​

Concept name for a text-based section of a report.​

111413​

Overall Assessment​

A title for a report section that summarizes all​

interpretation results for a report with one overriding​

assessment. E.g., benign or negative.​

111414​

Supplementary Data​

Conceptnameforacollectionofsupportingevidencefor​

a report.​

111415​

Additional evaluation requested​Priorstudyindicatesthatadditionalimagingbeperformed​

from prior study​

tofurtherevaluateasuspiciousorquestionableanatomic​

region.​

111416​

Follow-up at short interval from​Thepriorstudyrecommendedafollow-upbreastimaging​

prior study​

exam in 1 to 11 months (generally in 6 months).​

111417​

History of breast augmentation,​Prior breast augmentation (breast enlargement) and is​

asymptomatic​

not presenting with any symptoms.​

111418​

Review of an outside study​

Review or second opinion made on an image performed​

outside of the facility.​

111419​

Additional evaluation requested​Additional breast imaging performed at the time of the​

from abnormal screening exam​patient's screening mammogram.​

111420​

History of benign breast biopsy​Patient has had previous benign breast biopsies.​

111421​

Personalhistoryofbreastcancer​Patient has had a prior surgery such as a lumpectomy​

withbreastconservationtherapy​or quadrantectomy to remove malignant breast tissue,​

but breast tissue remains.​

111423​

Physical Examination Results​ The results of a physical examination performed on the​

patient, possibly including the results of inspection,​

palpation, auscultation, or percussion.​

111424​

Comparisontopreviousfindings​The result of assessing the current imaging exam in​

comparison to previous imaging exams.​

Page 1186​

DICOM PS3.16 2020a - Content Mapping Resource​

Code Value​

Code Meaning​

Definition​

Notes​

111425​

Intraluminal filling defect​

An abnormality observed during ductography where the​

ductal system within the breast fills in an abnormal​

pattern.Ductographyisanimagingexaminwhicharadio​

opaque contrast media is introduced into the ductal​

system of the breast through the nipple and images of​

the ductal system are obtained.​

111426​

Multiple filling defect​

During ductography an observation of more than one​

filling abnormality within the breast ductal system.​

111427​

Abrupt duct termination​

An abnormality observed during ductography where the​

ductal system within the breast terminates in an unusual​

fashion.​

111428​

Extravasation​

Abnormal flowage of contrast media within the breast​

noted on ductography.​

111429​

Duct narrowing​

An abnormality observed during ductography where the​

ductal system within the breast appears narrow.​

111430​

Cyst fill​

Duringductographyanobservationofthecontrastmedia​

filling a cyst within the breast.​

111431​

Instrument Approach​

The area and line within the anatomy through which a​

needle or instrument passes during an interventional​

procedure.​

111432​

Inferolateral to superomedial​

The line within the anatomy from the lower outer to the​

upper inner aspect. E.g., through which a needle or​

instrument passes in an interventional procedure.​

111433​

Inferomedial to superolateral​

The line within the anatomy from the lower inner to the​

upper outer aspect. E.g., through which a needle or​

instrument passes in an interventional procedure.​

111434​

Superolateral to inferomedial​

The line within the anatomy from the upper outer to the​

lower inner aspect. E.g., through which a needle or​

instrument passes in an interventional procedure.​

111435​

Superomedial to inferolateral​

The line within the anatomy from the upper inner to the​

lower outer aspect. E.g., through which a needle or​

instrument passes in an interventional procedure.​

111436​

Number of passes​

The number of times a biopsy instrument is passed​

through an area of interest.​

111437​

Number of specimens​

The number of biopsy specimens obtained from an​

interventional procedure.​

111438​

Needle in target​

An indicator of whether or not a biopsy or localizing​

needleinaninterventionalprocedureisseentobeinthe​

area of interest.​

111439​

Number of needles around​

Thenumberoflocalizingneedlesplacedaroundthearea​

target​

of interest in an interventional procedure.​

111440​

Incision made​

An indicator of whether or not an incision was made in​

the anatomy during an interventional procedure.​

111441​

Microclip placed​

An indicator of whether or not a radio opaque microclip​Retired. Replaced by​

was placed in the anatomy during an interventional​

(111123, DCM, "Marker​

procedure.​

placement")​

111442​

Confirmation of target​

Anindicatorofthedegreeofsuccessofaninterventional​

procedure.​

111443​

the specimen​

area of interest was fully excised and is noted in the​

resultant biopsy specimen.​

Page 1188​

DICOM PS3.16 2020a - Content Mapping Resource​

Code Value​

Code Meaning​

Definition​

Notes​

111469​

Sampling DateTime​

The date and time that the sample was collected from​

the patient.​

111470​

Uninvolved​

Indicates that the margin of the biopsy specimen was​

not involved with the tumor.​

111471​

Involved​

Indicates that the margin of the biopsy specimen was​

involved with the tumor.​

111472​

Nipple involved​

Indicates whether the nipple was involved in an​

interventional procedure or pathologic analysis.​

111473​

Number of nodes removed​

Indicates the number of lymph nodes removed.​

111474​

Number of nodes positive​

Indicates the number of lymph nodes removed that​

contain cancer cells.​

111475​

Estrogen receptor​

The result of a test for the presence of a protein that​

binds with estrogen.​

111476​

Progesterone receptor​

The result of a test for the presence of a protein that​

binds with progesterone.​

111477​

S Phase​

IndicatesthepercentageofcellsinSphase.Celldivision​

is defined by phases; the S phase is the stage during​

which DNA replicates.​

111478​

Non-bloody discharge (from​

The visible emission of non-bloody fluid from the nipple.​

nipple)​

111479​

Difficult physical/clinical​

The inability to discern normal versus abnormal breast​

examination​

tissue during palpation.​

111480​

Cancer elsewhere​

An indication that a patient has or had a malignant​

occurrence in an area of the body other than the breast.​

111481​

Saline implant​

A salt water filled prosthetic device implanted in the​

breast.​

111482​

Polyurethane implant​

A polymer based (plastic) prosthetic device implanted in​

the breast.​

111483​ Percutaneous silicone injection​The introduction of polymeric organic silicon based​

material through the skin, as for breast augmentation or​

reconstruction.​

111484​

Combination implant​

Aprostheticdevicethatcontainsmorethanonematerial​

implanted in the breast.​

111485​

Pre-pectoral implant​

A breast implant placed in front of the pectoralis major​

muscle.​

111486​

Retro-pectoral implant​

A breast implant placed behind the pectoralis major​

muscle.​

111487​

Mammographic (crosshair)​

Using X-Ray technique and a superimposed set of​

crossed lines for detection or placement.​

111488​

Mammographic (grid)​

UsingX-Raytechniqueandasuperimposedaperturefor​

detection or placement.​

111489​

Palpation guided​

Using physical touch for detection or placement.​

111490​

Vacuum assisted​

The performance of a biopsy procedure using a vacuum​

device attached to the biopsy needle.​

111491​

Abnormal discharge​

Unusual or unexpected emission of fluid.​

111492​

No complications​

Having experienced no adverse medical conditions​

related to or resulting from an interventional procedure.​